Načítá se...

Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

BACKGROUND: Trauma is a leading cause of mortality and morbidity, with traumatic brain injury (TBI) and uncontrolled hemorrhage responsible for the majority of these deaths. Recombinant activated factor VIIa (rFVIIa) is being investigated as an adjunctive hemostatic treatment for bleeding refractory...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kluger, Yoram, Riou, Bruno, Rossaint, Rolf, Rizoli, Sandro B, Boffard, Kenneth David, Choong, Philip Iau Tsau, Warren, Brian, Tillinger, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2007
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2206502/
https://ncbi.nlm.nih.gov/pubmed/17686152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6092
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!